Connable Office’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$299K Sell
6,457
-690
-10% -$31.6K 0.03% 184
2026
Q2
$234K Sell
7,147
-800
-10% -$28.8K 0.02% 211
2026
Q1
$281K Hold
7,947
– – 0.03% 184
2025
Q4
$323K Buy
+7,947
New +$346K 0.03% 186
2025
Q3
– Sell
-6,940
Closed -$361K – 227
2025
Q2
$361K Buy
6,940
+848
+14% +$46.5K 0.04% 175
2025
Q1
$368K Buy
6,092
+326
+6% +$21K 0.04% 166
2024
Q4
$395K Buy
5,766
+888
+18% +$61.9K 0.04% 167
2024
Q3
$351K Sell
4,878
-296
-6% -$20.9K 0.04% 178
2024
Q2
$359K Hold
5,174
– – 0.04% 173
2024
Q1
$414K Buy
5,174
+21
+0.4% +$1.87K 0.05% 156
2023
Q4
$564K Hold
5,153
– – 0.07% 120
2023
Q3
$520K Hold
5,153
– – 0.07% 116
2023
Q2
$700K Sell
5,153
-1,114
-18% -$136K 0.1% 104
2023
Q1
$651K Buy
6,267
+1,816
+41% +$176K 0.09% 108
2022
Q4
$395K Buy
4,451
+13
+0.3% +$1.08K 0.06% 140
2022
Q3
$356K Sell
4,438
-324
-7% -$30.6K 0.06% 141
2022
Q2
$456K Hold
4,762
– – 0.07% 119
2022
Q1
$707K Hold
4,762
– – 0.09% 107
2021
Q4
$675K Buy
4,762
+159
+3% +$22.5K 0.09% 121
2021
Q3
$602K Buy
4,603
+168
+4% +$22K 0.09% 116
2021
Q2
$610K Sell
4,435
-834
-16% -$114K 0.08% 110
2021
Q1
$688K Sell
5,269
-297
-5% -$35.7K 0.1% 110
2020
Q4
$623K Buy
5,566
+1,480
+36% +$140K 0.1% 113
2020
Q3
$321K Buy
+4,086
New +$333K 0.06% 141

Other funds holding CNMD

Connable Office's CNMD Position: Q3 2026 in Review

Connable Office reduced its CONMED (CNMD) stake by 9.7% in Q3 2026, selling an estimated $31.6K and leaving 6,457 shares worth $299K. The position accounts for 0.03% of the portfolio, ranked #184.

Connable Office first reported a position in CNMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $707K in Q1 2022. 213 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

  • Connable Office held 6,457 shares of CONMED worth $299K as of Q3 2026.
  • Connable Office sold 690 CONMED shares in Q3 2026, an estimated $31.6K.
  • CONMED made up 0.03% of Connable Office's portfolio in Q3 2026, its #184 holding.
  • Connable Office first reported a position in CONMED in Q3 2020 and has held it in 24 quarters since.
  • Connable Office's CONMED position peaked at $707K in Q1 2022.
  • 213 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on Connable Office's 13F filing for Q3 2026, filed 10 Nov 2026.